What is the Projected CAGR value of the Systemic Lupus Erythematosus Market?
Systemic Lupus Erythematosus Market is expected to grow at a CAGR of 7.3% during the forecast period 2024-2031.
Who are the Key players contributing to the market's growth?
Key players are Anthera Pharmaceuticals Inc., Eli Lilly, GlaxoSmithKline, F. Hoffmann-La Roche, Pfizer, Sanofi, Lycera Corporation, Bristol-Myers Squibb, ImmuPharma Plc, and Merck KGaA.